ID

33521

Descrizione

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Keywords

versioni (4)

1. 11/12/18 11/12/18 -
2. 06/06/19 06/06/19 -
3. 12/06/19 12/06/19 -
4. 27/09/21 27/09/21 -

Titolare del copyright

GSK group of companies

Caricato su

11 dicembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza